Saturn Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.00 M
- Revenue Growth 6.09%
- Profit Growth 214.01%
- Ebitda -0.78%
- Net Worth 68.00%
- Total Assets -35.88%
About Saturn Formulations
Saturn Formulations Private Limited (SFPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 October 2013 and has a history of 11 years and four months. Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹7.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Neeraj Sharda and Hans Sharda serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232CH2013PTC034756
-
Company No.
034756
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Oct 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Saturn Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Sharda
|
Director | 04-Oct-2013 | Current |
|
Hans Sharda
|
Director | 26-Mar-2018 | Current |
Financial Performance of Saturn Formulations.
Saturn Formulations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.09% increase. The company also saw a substantial improvement in profitability, with a 214.01% increase in profit. The company's net worth Soared by an impressive increase of 68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saturn Formulations?
Unlock access to Saturn Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Plenum Biotech Private LimitedNeeraj Sharda is a mutual person
-
Nebotic Laboratories Private LimitedNeeraj Sharda is a mutual person
Charges (Loans)
₹0
₹7.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2021 | Hdfc Bank Limited | ₹7.00 M | Satisfied |
How Many Employees Work at Saturn Formulations?
Unlock and access historical data on people associated with Saturn Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saturn Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saturn Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
